Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy: A Randomized Controlled Trial

NCT06271551 is registered in ClinicalTrials.gov with Central Finland Hospital District as lead sponsor.

NCT NCT06271551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy: A Randomized Controlled Trial
Lead sponsor
Central Finland Hospital District
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 31, 2024
Completion date
December 31, 2029
Enrollment
310 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer